Cardiff Oncology, Inc. (CRDF)

Cardiff Oncology Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	10.14	51.47	21.66	16.35	11.94	130.98
Short-Term Investments	50.46	40.28	53.17	88.92	128.88	-
Cash & Short-Term Investments	60.59	91.75	74.82	105.27	140.82	130.98
Cash Growth	5.07%	22.62%	-28.92%	-25.25%	7.51%	1184.72%
Accounts Receivable	0.25	0.77	0.29	0.77	0.54	0.32
Other Receivables	-	0.4	0.6	-	-	-
Receivables	0.25	1.17	0.89	0.77	0.54	0.32
Prepaid Expenses	0.96	2.14	1.7	5.25	4.77	2.06
Total Current Assets	61.8	95.05	77.41	111.28	146.13	133.36
Property, Plant & Equipment	1.43	2.07	2.95	3.52	3.18	0.97
Other Long-Term Assets	0.55	0.07	1.28	1.39	0.24	0.4
Total Assets	63.78	97.19	81.64	116.19	149.54	134.73
Accounts Payable	2.44	4.82	1.97	1.96	1.44	1.37
Accrued Expenses	11.54	7.9	7.78	5.18	4.11	3.46
Current Portion of Leases	0.73	0.71	0.69	0.68	0.55	0.86
Other Current Liabilities	-	-	-	-	0.46	0.43
Total Current Liabilities	14.71	13.43	10.44	7.81	6.56	6.12
Long-Term Leases	0.28	0.81	1.46	2.04	2.57	0.01
Other Long-Term Liabilities	-	-	-	-	-	0.44
Total Liabilities	14.99	14.24	11.9	9.85	9.13	6.57
Common Stock	0.01	0.01	0	0	0	0
Additional Paid-In Capital	471.55	467.09	409.34	404.83	400.5	361.82
Retained Earnings	-422.81	-384.18	-339.54	-298.1	-259.81	-231.5
Comprehensive Income & Other	0.05	0.03	-0.07	-0.4	-0.28	-2.17
Total Common Equity	48.79	82.95	69.74	106.34	140.42	128.16
Shareholders' Equity	48.79	82.95	69.74	106.34	140.42	128.16
Total Liabilities & Equity	63.78	97.19	81.64	116.19	149.54	134.73
Total Debt	1.01	1.52	2.15	2.72	3.12	0.87
Net Cash (Debt)	59.58	90.22	72.67	102.55	137.7	130.11
Net Cash Growth	6.43%	24.15%	-29.13%	-25.53%	5.83%	1436.34%
Net Cash Per Share	0.94	1.89	1.63	2.35	3.53	6.23
Filing Date Shares Outstanding	67.36	66.52	44.68	44.68	43.31	37.05
Total Common Shares Outstanding	67.1	66.52	44.68	44.68	41.96	36.78
Working Capital	47.1	81.63	66.97	103.48	139.57	127.24
Book Value Per Share	0.73	1.25	1.56	2.38	3.35	3.48
Tangible Book Value	48.79	82.95	69.74	106.34	140.42	128.16
Tangible Book Value Per Share	0.73	1.25	1.56	2.38	3.35	3.48
Machinery	2.5	2.47	2.42	2.12	1.86	1.67
Leasehold Improvements	2.57	2.57	2.57	2.56	1.96	1.96

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q